MasTec
MTZ
$144.71
-12.17%
MasTec, Inc. is a North American infrastructure construction and engineering firm that builds, installs, maintains, and upgrades communications networks, power delivery systems, pipelines, renewable energy facilities, and other heavy infrastructure, reporting across five segments (Communications, Clean Energy & Infrastructure, Pipeline Infrastructure, Power Delivery, and Other). With roughly 42,000 employees and a diversified multi-end-market model, MasTec occupies a distinctive position as a scaled specialty contractor that sits at the intersection of several secular capex cycles — fiber and telecom buildouts, grid modernization and power delivery, and utility-scale renewables — rather than being a single-cycle play. The current investor debate centers on whether the company's record $24.5 billion backlog is a genuine launchpad for 2027 growth or a figure inflated by softness, given that roughly 34% of the backlog is not firm and the Communications segment is weakening even as power delivery demand surges. Management's upgraded 2026 EPS outlook (roughly 42% growth) and surging power delivery demand have kept the long-term bull case intact, but near-term pipeline delays, margin volatility, and a sharp share-price drawdown have made execution and backlog conversion the central points of contention.…
MTZ
MasTec
$144.71
Related headlines
Investment Opinion: Should I buy MTZ Today?
Rating: HOLD with a speculative accumulation bias — the risk/reward has shifted from 'avoid' toward 'early,' but the tape has not yet confirmed a bottom. The core thesis is that MTZ trades at 13.48x forward EPS of ~$23.25 (versus a 42.46x trailing PE on depressed $0.024 trailing EPS), a multiple at the bottom of its own historical band, while 21 of 22 analysts rate it Buy with a $301.09 average target implying 82.7% upside — yet the stock sits just 5.9% above its $147.49 52-week low after a -56.88% six-month collapse, so the market is pricing skepticism the consensus has not yet acknowledged.
Supporting evidence is genuinely two-sided. Revenue is accelerating at 29.88% YoY ($5.15B in Q3 2026 vs. $3.97B), with sequential growth every quarter of 2026 ($3.83B → $4.37B → $5.15B), and the $24.5B backlog underpins multi-year visibility. Free cash flow is positive at $404.6M TTM ($180.1M in Q3), debt-to-equity of 0.86 with ~4.5x interest coverage is manageable, and the PS ratio of 1.18 and EV/Sales of 1.05 are modest versus an Engineering & Construction sector that typically trades at mid-teens to low-20s forward earnings. But the offsetting data are equally concrete: Q3 gross margin of 12.83% is below 13.56% a year ago, operating margin of 5.35% is down from 8.99%, net margin is just 2.92%, and roughly 34% of the backlog is not firm while Communications weakens — meaning the 42% EPS growth outlook requires margin recovery that has not yet appeared.
The rating would upgrade to Buy on two confirmations: (1) a quarterly print showing gross margin back above 13.5% and operating margin above 7%, with firm backlog conversion accelerating, and (2) technical stabilization — a higher low above $147.49 and reclaim of the $200-220 supply zone. It would downgrade to Sell if Q4 margins compress further below 12%, if analysts begin cutting the $301 average target toward the $220 low, or if the stock breaks $147.49 on volume. Verdict: fairly valued to modestly undervalued on forward earnings, but expensive on trailing fundamentals (EV/EBITDA 17.33x, PB 5.19x) — this is a 'show-me' value setup, not a confirmed bargain.
Sign up to view all
MTZ 12-Month Price Forecast
The setup is a classic divergence between a deeply de-rated multiple and an unconfirmed fundamental recovery: at 13.48x forward earnings with 29.88% revenue growth and a $24.5B backlog, the stock prices in substantial skepticism, but margins are still compressing year-over-year and 34% of backlog is not firm, so the earnings inflection the multiple assumes has not been proven. Analyst conviction (21 Buys, $301 average target) is intact but has not been marked to the collapsing price, which cuts both ways — either the market is wrong or estimates are about to fall. The broken technical trend (-56.88% six months, -63.67% max drawdown, beta 1.919) argues for patience rather than conviction buying until a base forms above $147.49. I would upgrade to bullish on a margin-recovery print plus technical stabilization above the $200-220 supply zone, and downgrade to bearish on a break of $147.49 or the first round of target cuts toward $220.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on MasTec's 12-month outlook, with a consensus price target around $301.09 and implied upside of +108.1% versus the current price.
Average Target
$301.09
22 analysts
Implied Upside
+108.1%
vs. current price
Analyst Count
22
covering this stock
Price Range
$220 - $500
Analyst target range
Coverage is robust, with 22 analysts and an overwhelmingly bullish distribution of 21 Buy ratings, 1 Hold, and 0 Sells, yielding a consensus recommendation of 'strong_buy' (mean rating 1.27 on a 1-5 scale). The average target price of $301.09 implies roughly 82.7% upside from the current $164.76, a gap that is unusually wide and signals that analysts have not yet marked their targets to the collapsing share price — the consensus is bullish in the extreme, but the market is voting otherwise. This divergence between analyst sentiment and price action is a classic setup where either the stock is deeply mispriced or estimates are about to be cut.
The target range is extraordinarily wide, from a low of $220 (still 33.5% above the current price) to a high of $500 (203.5% upside), a spread that reflects high uncertainty about backlog conversion, margin trajectory, and the pace of power-delivery demand. The high target assumes multiple expansion back toward prior levels and successful conversion of the $24.5 billion backlog into revenue at improving margins, while the low target of $220 still embeds a recovery from current levels, meaning even the bear case is constructive — a sign that analysts view the selloff as overdone. Institutional ratings show a steady stream of reaffirmations (Piper Sandler, Cantor Fitzgerald, TD Cowen, Truist, Citigroup, Barclays, JP Morgan, KeyBanc, Stifel all maintaining Buy/Overweight through October-November 2026) with no downgrades, suggesting conviction remains intact despite the price collapse; however, the absence of fresh upgrades or raised targets during the decline may indicate analysts are waiting for evidence of stabilization before adjusting, and the wide target spread warrants caution for position sizing.
Bulls vs Bears: MTZ Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a confirmed downtrend (-56.9% over six months, -63.67% max drawdown), margins are compressing year-over-year, and the market is clearly voting against the bullish analyst consensus despite 21 of 22 Buy ratings. However, the bull case is not weak — revenue is accelerating at 29.88%, the forward PE of 13.5x is at the bottom of the historical band, and the $24.5 billion backlog provides real multi-year visibility. The single most important tension is backlog conversion and margin recovery: if the firm portion of the backlog converts into revenue at improving margins over the next two quarters, the 13.5x forward multiple is a deep-value opportunity; if estimates are cut instead, the stock has further to fall. Until there is evidence of a technical base and margin stabilization, the risk/reward favors patience over conviction buying.
Bullish
- Revenue accelerating at nearly 30%: Q3 2026 revenue hit $5.15 billion, up 29.88% year-over-year from $3.97 billion, with sequential expansion every quarter of 2026 ($3.83B → $4.37B → $5.15B). This is genuine, broad-based top-line momentum led by Clean Energy & Infrastructure at $1.83 billion, not a one-off comp.
- Forward PE of 13.5x is deeply discounted: On consensus 2027 EPS of roughly $23.25, MTZ trades at just 13.48x forward earnings versus a trailing PE of 42.46x and a sector that typically trades in the mid-teens to low-20s. The PS ratio has collapsed from 7.43x in Q2 2026 to 1.18x today, placing the stock at the bottom of its own historical valuation band.
- Analyst consensus overwhelmingly bullish: 21 of 22 analysts rate the stock Buy with zero Sells, yielding a 'strong_buy' consensus (mean rating 1.27). The average target of $301.09 implies 82.7% upside from $164.76, and even the lowest target of $220 sits 33.5% above the current price — analysts view the selloff as overdone.
- Record $24.5B backlog and power demand: The $24.5 billion backlog underpins multi-year visibility, and management's upgraded 2026 EPS outlook of roughly 42% growth is backed by surging power delivery demand tied to grid modernization. Even discounting the 34% non-firm portion, the firm backlog remains substantial.
Bearish
- Broken trend, down 56.9% in six months: The stock has fallen 56.88% over six months and 38.12% over three months, with a max drawdown of -63.67%, sitting just 5.9% above its 52-week low of $147.49. Momentum is accelerating to the downside (-12.05% in one month), a classic falling-knife profile.
- Margins compressing year-over-year: Q3 2026 gross margin of 12.83% is below the 13.56% posted in Q3 2025, and operating margin of 5.35% is down from 8.99% a year earlier. Net margin of just 2.92% leaves almost no cushion, and trailing EPS of $0.024 shows how thin profitability really is.
- Backlog quality is questionable: Roughly 34% of the $24.5 billion backlog is not firm, and the Communications segment is weakening even as power delivery surges. This casts doubt on whether the headline backlog is a genuine 2027 launchpad or an inflated figure that could convert at lower margins.
- Valuation depends entirely on an earnings rebound: The 42.46x trailing PE versus 13.48x forward PE means the entire thesis rests on EPS inflecting to ~$23.25. If estimates slip, the stock is not cheap on current earnings, and the EV/EBITDA of 17.33x and PB of 5.19x are rich for a low-margin contractor.
MTZ Technical Analysis
MasTec is in a pronounced, sustained downtrend, with the stock down 16.37% over the past year and a staggering 56.88% over six months, a decline that has erased most of the prior advance and left shares trading at just 164.76 — only about 5.9% above the 52-week low of 147.49 and roughly 62.7% below the 52-week high of 441.43. Measured against its 52-week range, the stock sits at approximately 5.9% of the band, deep in the bottom decile, which signals capitulation-style selling rather than a healthy pullback; the maximum drawdown of -63.67% confirms this is a broken trend, not a consolidation. For investors, this positioning is a classic 'falling knife' profile where value-oriented buyers must demand evidence of a base before committing capital, as momentum remains firmly negative.
Short-term momentum is decisively negative and accelerating on the downside: the stock is down 12.05% over the past month and 38.12% over three months, meaning the recent decline is steeper than the longer-term trend and represents an acceleration of selling rather than a stabilization. This is corroborated by the most recent session, in which shares fell 5.79% (from 174.89 to 164.76) on volume of roughly 1.38 million shares, a sharp single-day move that suggests fresh negative catalysts or forced selling. Relative strength is uniformly poor — -5.13 versus SPY over one month, -31.61 over three months, and -52.89 over six months — indicating the stock is underperforming the market by a wide and widening margin, a divergence that argues against a simple mean-reversion bounce and points to company-specific deterioration layered on top of a soft tape (SPY itself is down 6.92% over one month).
Key technical levels are stark: immediate support sits at the 52-week low of 147.49, and a breakdown below that level would signal a new leg lower with little historical reference for buyers, while meaningful resistance is far overhead at the 441.43 high, with intermediate supply likely clustered around the 200-220 area where the stock traded in early November before the latest leg down. The stock's beta of 1.919 means it is roughly 92% more volatile than the S&P 500, so a 10% market move implies nearly a 19% move here — a critical consideration for position sizing, as drawdowns can compound violently (as the -63.67% max drawdown demonstrates). With a short ratio of 3.13, short interest is moderate but not extreme, suggesting bears are positioned but not overcrowded, leaving room for further downside if support at 147.49 fails.
Beta
1.92
1.92x market volatility
Max Drawdown
-66.9%
Largest decline past year
52-Week Range
$143-$441
Price range past year
Annual Return
-24.6%
Cumulative gain past year
| Period | MTZ Return | S&P 500 |
|---|---|---|
| 1m | -20.0% | -10.8% |
| 3m | -45.7% | -9.9% |
| 6m | -62.1% | -7.5% |
| 1y | -24.6% | +5.7% |
| ytd | -36.4% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MTZ Fundamental Analysis
MasTec's revenue trajectory is genuinely strong and accelerating: Q3 2026 revenue reached $5.15 billion, up 29.88% year-over-year from $3.97 billion in Q3 2025, and the sequential progression through 2026 ($3.83B in Q1, $4.37B in Q2, $5.15B in Q3) shows consistent quarter-over-quarter expansion. The growth is broad-based but led by Clean Energy & Infrastructure at $1.83 billion, followed by Communications at $806.9 million and Pipeline Infrastructure at $724.1 million, with power delivery demand cited as a key driver. This top-line momentum, combined with a record $24.5 billion backlog, supports the multi-year growth thesis, though the caveat that roughly 34% of backlog is not firm and Communications is weakening tempers the quality of that growth and explains why the market has discounted the headline numbers.
Profitability is positive but thin and volatile: Q3 2026 net income was $150.6 million on a 2.92% net margin, with gross margin of 12.83% and operating margin of 5.35%, figures that are typical-to-slightly-below par for a low-margin specialty contractor where single-digit operating margins are the norm. The margin trajectory is uneven — gross margin was 9.30% in Q1 2026, 12.72% in Q2, and 12.83% in Q3, showing improvement off a weak first quarter, but the Q3 gross margin of 12.83% is still below the 13.56% posted in Q3 2025, indicating year-over-year compression despite sequential recovery. Trailing EPS of just $0.024 and a 2.79% net margin underscore how little cushion exists; the company's profitability is highly sensitive to project mix, weather, and execution, and the 42% EPS growth outlook depends on margin recovery that has yet to fully materialize.
Balance sheet and cash flow present a mixed picture: debt-to-equity stands at 0.86 (total debt to capitalization of 53.7%), current ratio is 1.32, and TTM free cash flow is $404.6 million, but the quarterly cash flow is lumpy — Q3 2026 FCF was $180.1 million while Q2 was negative $70.1 million, reflecting heavy working-capital swings (Q3 change in working capital was -$58.5 million). ROE of 12.24% and ROA of 4.43% are respectable for the sector but not exceptional, and the company funded $1.37 billion of acquisitions in Q3 2026 partly through $1.33 billion of net financing inflows, indicating reliance on external capital for growth. The FCF yield is modest relative to the $16.9 billion market cap, and with interest expense of $61.8 million in Q3 and interest coverage around 4.5x, financial risk is manageable but the balance sheet is not a source of strength — cash of $481.8 million against a large debt load means the company must keep executing to service obligations.
Quarterly Revenue
$5.2B
2026-09
Revenue YoY Growth
+29.9%
YoY Comparison
Gross Margin
12.8%
Latest Quarter
Free Cash Flow
$404634000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MTZ Overvalued?
Because MasTec is profitable (Q3 2026 net income of $150.6 million), the PE ratio is the appropriate primary metric, and the picture is bifurcated: the trailing PE is 42.46x on depressed trailing EPS of $0.024, while the forward PE is just 13.48x based on consensus 2027 EPS estimates of roughly $23.25. This enormous gap — trailing 42x versus forward 13.5x — implies the market expects a dramatic earnings inflection, consistent with management's 42% EPS growth outlook, but it also means the valuation is entirely dependent on that recovery materializing; if estimates slip, the stock is not cheap on current earnings. The PEG ratio of 0.29 and PS ratio of 1.18 suggest the stock looks inexpensive relative to growth and sales, but those metrics flatter a low-margin business.
Against the Engineering & Construction industry, MasTec's PS ratio of 1.18 and EV/Sales of 1.05 are modest, while its EV/EBITDA of 17.33x is elevated for a contractor and its PB ratio of 5.19 is rich, reflecting the market's willingness to pay up for backlog visibility and power-delivery exposure. The forward PE of 13.5x versus a sector that typically trades in the mid-teens to low-20s suggests the stock is now at a discount on forward earnings — a reversal from its historical premium — which could be justified by the margin compression and backlog-quality concerns, or could represent an opportunity if execution improves. The spread between the 42x trailing and 13.5x forward multiple is the key valuation signal: the market is pricing a sharp earnings rebound, and the stock's 56.9% six-month decline has compressed the multiple to levels that assume significant skepticism.
Historically, MasTec's PE has ranged wildly — from over 100x in early 2026 (103x in Q1, 62x in Q2) down to 28x in Q3 2026 — and its PS ratio has fallen from 7.43x in Q2 2026 to 1.18x today, a dramatic de-rating that places the stock near the bottom of its own historical valuation band. The PB ratio of 5.19 is above the 3.1-4.2x range seen through 2024-2025, but the PS compression is the more telling signal: the market has repriced the stock from a premium growth multiple to a deep-value multiple in a matter of months. This suggests either a genuine value opportunity if fundamentals hold, or that the market is pricing in fundamental deterioration — the truth likely lies in backlog conversion and margin recovery over the next two quarters.
PE
42.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 22x~147x
vs. Industry Avg
27.6x
Industry PE ~27.6x*
EV/EBITDA
17.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on thin, volatile margins and a growth model reliant on external capital. Q3 2026 net margin was just 2.92% and operating margin 5.35%, down from 8.99% a year earlier, meaning small project-mix or weather disruptions swing earnings sharply. Debt-to-equity of 0.86 (53.7% debt-to-capitalization) and $61.8 million of quarterly interest expense mean the company must keep executing to service obligations, and the $1.37 billion of Q3 acquisitions were funded partly through $1.33 billion of net financing inflows. Cash flow is lumpy — Q3 FCF of $180.1 million followed a negative $70.1 million in Q2 — and with roughly 34% of the $24.5 billion backlog not firm, revenue visibility is weaker than the headline suggests. Market and competitive risks stem from extreme valuation sensitivity and a broken technical trend. The stock trades at 42.46x trailing earnings but only 13.48x forward, so any estimate cut would instantly make it look expensive; EV/EBITDA of 17.33x and PB of 5.19x are rich for a contractor. Beta of 1.919 amplifies market moves, and relative strength of -52.89 versus SPY over six months shows company-specific deterioration layered on a soft tape. Competitive pressure is real: peers like Dycom ($12.2B backlog) and EMCOR ($18.57B backlog) are winning fiber and infrastructure work, and the weakening Communications segment signals share and pricing pressure in that end market. The worst-case scenario is a chain of estimate cuts: if the non-firm backlog fails to convert, Communications keeps weakening, and margins stay compressed, analysts would be forced to mark their $301 average target down toward the $220 low. From $164.76, a retest of the 52-week low of $147.49 implies roughly -10.5%, while a break below that level — with no historical reference for buyers — could extend toward the -63.67% max drawdown profile, implying a loss of 10% to 25%+ in an adverse scenario. The moderate short ratio of 3.13 leaves room for further downside if support at $147.49 fails.
FAQ
The most severe risk is estimate risk: the entire 13.48x forward multiple rests on EPS inflecting to ~$23.25, and with Q3 gross margin at 12.83% (down from 13.56%) and operating margin at 5.35% (down from 8.99%), any cut to 2027 estimates would instantly make the stock look expensive at 42.46x trailing. Second is backlog-quality and competitive risk — roughly 34% of the $24.5B backlog is not firm, the Communications segment is weakening, and peers like Dycom ($12.2B backlog) and EMCOR ($18.57B backlog) are competing for the same fiber and infrastructure work. Third is financial risk: net margin of just 2.92%, debt-to-equity of 0.86, $61.8M of quarterly interest expense at ~4.5x coverage, and lumpy cash flow (Q2 FCF of -$70.1M versus Q3's +$180.1M) leave little cushion. Fourth is market risk: beta of 1.919 and relative strength of -52.89 versus SPY over six months mean a soft tape compounds the drawdown, and a break of $147.49 support has no historical reference for buyers.
The scenario framework assigns 50% to a base case of $180-240, where high-teens to ~30% revenue growth continues but margin recovery stays gradual, leaving EPS below the ~$23.25 consensus and the stock basing above $147.49 before partially retracing toward the $200-220 zone. The 25% bull case targets $301-400, requiring gross margin above 13.5%, operating margin back toward 7-9%, firm backlog conversion in power delivery, and multiple re-rating toward the $301.09 average analyst target. The 25% bear case targets $120-147, driven by non-firm backlog failing to convert, further Communications deterioration, analyst target cuts toward the $220 low, and a volume break of the $147.49 52-week low. The base case is most likely because revenue momentum (29.88% YoY to $5.15B) and the $24.5B backlog are real, but the margin inflection the forward multiple assumes has not yet been proven — the key assumption is that gross margin stabilizes in the 12.5-13.5% band rather than recovering to prior-year levels.
The answer depends entirely on which earnings number you trust. On trailing EPS of $0.024 the stock trades at 42.46x, which looks expensive, but on consensus 2027 EPS of ~$23.25 it trades at just 13.48x forward — below the mid-teens to low-20s range typical of Engineering & Construction peers. Supporting the cheaper read, the PS ratio has collapsed from 7.43x in Q2 2026 to 1.18x today and EV/Sales is 1.05, while the PEG of 0.29 flatters a low-margin business; against that, EV/EBITDA of 17.33x and PB of 5.19x are rich for a contractor with a 2.79% net margin. The market is therefore pricing substantial skepticism about the earnings rebound — the 42% EPS growth outlook requires margin recovery that has not yet appeared, with Q3 operating margin at 5.35% versus 8.99% a year ago. Verdict: fairly valued to modestly undervalued on forward earnings, expensive on trailing fundamentals — a 'show-me' discount rather than a confirmed bargain.
From a risk/reward standpoint MTZ is an early-stage value setup rather than a confirmed bargain: it trades at 13.48x forward EPS of ~$23.25 versus a 42.46x trailing PE, and the $301.09 average analyst target implies 82.7% upside, with even the $220 low target 33.5% above the $164.76 price. The catch is that the market is voting against that consensus — the stock is down 56.88% over six months and sits just 5.9% above its $147.49 52-week low, with Q3 gross margin of 12.83% below the 13.56% posted a year earlier. The biggest downside risk is a break of $147.49 support, which would imply roughly -10.5% immediately and potentially 10-25%+ further given the -63.67% max drawdown profile. It is a reasonable buy only for risk-tolerant investors with a multi-year horizon who size positions for a 1.919 beta and wait for margin stabilization plus a technical base; income seekers and short-term traders should stay away given the zero dividend and broken trend.
MTZ is best suited to a long-term holding period of at least 18-24 months, because the thesis depends on backlog conversion and margin recovery that play out over multiple quarters rather than a single catalyst. The stock is a high-volatility vehicle — beta of 1.919, a -63.67% max drawdown, and a 56.88% six-month decline — so short-term trading requires precise timing against a firmly negative trend (-12.05% in one month) and offers poor risk/reward for most investors. There is no income support: the dividend yield and payout ratio are both 0, so total return depends entirely on price appreciation and the EPS rebound from $0.024 trailing to ~$23.25 forward. Earnings visibility is moderate — the $24.5B backlog helps, but 34% is not firm and quarterly margins have swung from 9.30% to 12.83% gross through 2026. A staged accumulation approach, adding on confirmation of margin stabilization and a base above $147.49, fits the risk profile better than either a single entry or a short-term trade.

